Long Noncoding RNA MALAT1 Promotes Colorectal Cancer Progression by Acting as a ceRNA of miR‐508‐5p to Regulate RAB14 Expression
Chen Zhang, Kunhou Yao, Junjie Zhang, Chenyu Wang, Chaoyang Wang, Changjiang Qin
Abstract
Open-access reader
Chen Zhang, Kunhou Yao, Junjie Zhang, Chenyu Wang, Chaoyang Wang, Changjiang Qin
Abstract
Open-access reader
Accumulating evidence suggested that lncRNA MALAT1 plays critical roles in the commencement and progression of malignant cancers. Nevertheless, the function of MALAT1 in colorectal cancer (CRC) remains largely unknown. In the present study, we reported that MALAT1 expression is significantly upregulated in CRC and correlated with advanced TNM stage, lymph node metastasis, and worse prognosis in patients. Functional assays revealed that MALAT1 knockdown reduced CRC cell growth and invasion abilities in vitro. Mechanistically, we discovered that MALAT1 may serve as a competing endogenous RNA (ceRNA) to miR‐508‐5p in CRC progression. Bioinformatics analysis and luciferase assays confirmed that RAB14 acts as a target of miR‐508‐5p. In addition, downregulation of RAB14 reduced the progression of CRC. Collectively, our findings indicated that MALAT1 could promote CRC progress by sponging miR‐508‐5p and enhancing RAB14 expression, which provides a therapeutic target in CRC treatment.
OpenAlex reports 25 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Accumulating evidence suggested that lncRNA MALAT1 plays critical roles in the commencement and progression of malignant cancers. Nevertheless, the function of MALAT1 in colorectal cancer (CRC) remains largely unknown. In the present study, we reported that MALAT1 expression is significantly upregulated in CRC and correlated with advanced TNM stage, lymph node metastasis, and worse prognosis in patients. Functional assays revealed that MALAT1 knockdown reduced CRC cell growth and invasion abilities in vitro. Mechanistically, we discovered that MALAT1 may serve as a competing endogenous RNA (ceRNA) to miR‐508‐5p in CRC progression. Bioinformatics analysis and luciferase assays confirmed that RAB14 acts as a target of miR‐508‐5p. In addition, downregulation of RAB14 reduced the progression of CRC. Collectively, our findings indicated that MALAT1 could promote CRC progress by sponging miR‐508‐5p and enhancing RAB14 expression, which provides a therapeutic target in CRC treatment.
Key concepts: MALAT1, Competing endogenous RNA, Long non-coding RNA, microRNA, Biology, Colorectal cancer, Cancer research, RNA